Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 79, Issue 3 , Pages 109-115 , September 2008

Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease

  • Marika Massaro

      Affiliations

    • C.N.R. Institute of Clinical Physiology, Pisa and Lecce, Italy
    • University of Lecce, Ecotekne, Lecce, Italy
    • ,
  • Egeria Scoditti

      Affiliations

    • C.N.R. Institute of Clinical Physiology, Pisa and Lecce, Italy
    • University of Lecce, Ecotekne, Lecce, Italy
    • ,
  • Maria Annunziata Carluccio

      Affiliations

    • C.N.R. Institute of Clinical Physiology, Pisa and Lecce, Italy
    • University of Lecce, Ecotekne, Lecce, Italy
    • ,
  • Raffaele De Caterina

      Affiliations

    • “G. d’Annunzio” University, 66013 Chieti, Italy
    • C.N.R. Institute of Clinical Physiology, Pisa and Lecce, Italy
    • Corresponding Author InformationCorresponding author at: Institute of Cardiology and Center of Excellence on Aging, “G. d’Annunzio” University–Chieti, C/o Ospedale SS. Annunziata, Via dei Vestini, 66013 Chieti, Italy. Tel.: +39087141512; fax: +390871402817.

References 

  1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952
  2. He K, Song Y, Daviglus ML, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation. 2004;109:2705–2711
  3. Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am. J. Clin. Nutr. 2006;84:5–17
  4. Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 2006;332:752–760
  5. Serhan CN, Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 2008;153(Suppl. 1):S200–S215
  6. Freeman BA, Baker PR, Schopfer FJ, Woodcock SR, Napolitano A, d’Ischia M. Nitro-fatty acid formation and signaling. J. Biol. Chem. 2008;1–16
  7. De Caterina R, Madonna R, Zucchi R, La Rovere MT. Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside. Am. Heart J. 2003;146:420–430
  8. Chrysohoou C, Panagiotakos DB, Pitsavos C, et al. Long-term fish consumption is associated with protection against arrhythmia in healthy persons in a Mediterranean region—the ATTICA study. Am. J. Clin. Nutr. 2007;85:1385–1391
  9. Billman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation. 1999;99:2452–2457
  10. Leaf A, Kang JX, Xiao YF, Billman GE. n-3 Fatty acids in the prevention of cardiac arrhythmias. Lipids. 1999;34(Suppl):S187–S189
  11. Hallaq H, Smith TW, Leaf A. Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc. Natl. Acad. Sci. USA. 1992;89:1760–1764
  12. Charnock JS, McLennan PL, Abeywardena MY. Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol. Cell Biochem. 1992;116:19–25
  13. De Caterina R, Zampolli A. From asthma to atherosclerosis—5-lipoxygenase, leukotrienes, and inflammation. N. Engl. J. Med. 2004;350:4–7
  14. Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. (Lond.). 2004;107:1–11
  15. Vanschoonbeek K, de Maat MP, Heemskerk JW. Fish oil consumption and reduction of arterial disease. J. Nutr. 2003;133:657–660
  16. Gotto AM. Triglyceride as a risk factor for coronary artery disease. Am. J. Cardiol. 1998;82:22Q–25Q
  17. Ting HJ, Stice JP, Schaff UY, et al. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ. Res. 2007;100:381–390
  18. Bays HE, Tighe AP, Sadovsky R, Davidson MH. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev. Cardiovasc. Ther. 2008;6:391–409
  19. Horton JD, Bashmakov Y, Shimomura I, Shimano H. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. USA. 1998;95:5987–5992
  20. Yoshikawa T, Shimano H, Yahagi N, et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J. Biol. Chem. 2002;277:1705–1711
  21. Wahli W, Braissant O, Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem. Biol. 1995;2:261–266
  22. Jump DB. The biochemistry of n-3 polyunsaturated fatty acids. J. Biol. Chem. 2002;277:8755–8758
  23. Jump DB, Clarke SD. Regulation of gene expression by dietary fat. Annu. Rev. Nutr. 1999;19:63–90
  24. Edwards PA, Kast HR, Anisfeld AM. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J. Lipid Res. 2002;43:2–12
  25. Davidson MH. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am. J. Cardiol. 2006;98:27i–33i
  26. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens. 2002;20:1493–1499
  27. Ueshima H, Stamler J, Elliott P, et al. Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure: INTERMAP study. Hypertension. 2007;50:313–319
  28. Nestel P, Shige H, Pomeroy S, Cehun M, Abbey M, Raederstorff D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am. J. Clin. Nutr. 2002;76:326–330
  29. Mori TA, Watts GF, Burke V, Hilme E, Puddey IB, Beilin LJ. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation. 2000;102:1264–1269
  30. Li Q, Zhang Q, Wang M, et al. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch. Biochem. Biophys. 2007;466:250–259
  31. De Caterina R, Zampolli A, Lazzerini G, Libby P. Endothelial activation and the initiation of atherosclerosis. In:  De Caterina R,  Libby P editor. Endothelial Dysfunction and Vascular Disease. Singapore: Blackwall Futura; 2007;p. 26–35
  32. De Caterina R, Cybulsky MA, Clinton SK, Gimbrone MAJr, Libby P. Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukot. Essent. Fatty Acids. 1995;52:191–195
  33. Massaro M, Basta G, Lazzerini G, et al. Quenching of intracellular ROS generation as a mechanism for oleate-induced reduction of endothelial activation and early atherogenesis. Thromb. Haemost. 2002;88:176–375
  34. Mishra A, Chaudhary A, Sethi S. Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 2004;24:1621–1627
  35. Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003;361:477–485
  36. Doyle B, Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J. Am. Coll. Cardiol. 2007;49:2073–2080
  37. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am. J. Cardiol. 2003;91(suppl.):3A–6A
  38. Kanayasu T, Morita I, Nakao-Hayashi J, et al. Eicosapentaenoic acid inhibits tube formation of vascular endothelial cells in vitro. Lipids. 1991;26:271–276
  39. Tsuji M, Murota SI, Morita I. Docosapentaenoic acid (22:5, n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor. Prostaglandins Leukot. Essent. Fatty Acids. 2003;68:337–342
  40. Jones MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat. Med. 1999;5:1418–1423
  41. Massaro M, Habib A, Lubrano L, et al. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCepsilon inhibition. Proc. Natl. Acad. Sci. USA. 2006;103:15184–15189
  42. Corcoran M, Stetler-Stevenson W, DeWitt D, Whal L. Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2 and matrix metalloproteinase production by human monocytes. Arch. Biochem. Biophys. 1994;310:481–488
  43. M. Massaro, E. Scoditti, M. Carluccio, et al., Omega-3 fatty acids differentially affect the release of matrix metalloproteinases and tissue inhibitors of metalloproteinases by monocytes/macrophages: possible contribution to plaque stability. American Heart Association, Dallas, TX, 2005.
  44. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195–2224
  45. Stillwell W, Shaikh SR, Zerouga M, Siddiqui R, Wassall SR. Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod. Nutr. Dev. 2005;45:559–579
  46. Li Q, Engelhardt JF. Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase. J. Biol. Chem. 2006;281:1495–1505
  47. Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clin. Sci. (Lond.). 2005;109:217–226
  48. Chang MS, Chen BC, Yu MT, Sheu JR, Chen TF, Lin CH. Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, ERK, and NF-kappaB, but not p38 MAPK, pathways. Cell. Signal. 2005;17:299–310
  49. Jude S, Roger S, Martel E, et al. Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Prog. Biophys. Mol. Biol. 2006;90:299–325
  50. Touyz RM, Schiffrin EL. Peroxisome proliferator-activated receptors in vascular biology—molecular mechanisms and clinical implications. Vascul. Pharmacol. 2006;45:19–28

PII: S0952-3278(08)00126-9

doi: 10.1016/j.plefa.2008.09.009

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 79, Issue 3 , Pages 109-115 , September 2008

Article Tools

* Image Usage & Resolution